In MCD-induced NASH, NLRP3 inflammasome sensors and inflammasome activation involved both BM-derived and non-BM-derived cells in the liver via HMBG1-TLR9-MyD88 pathways [59]. The gene discussed is TLR9; the disease is metabolic dysfunction-associated steatohepatitis.